Evaluating the Role of Cardiac Screening Before Athletic Participation: An Untapped Opportunity?
-
By
-
Aaron Baggish
-
October 14, 2025
Clinical Scorecard: Evaluating the Role of Cardiac Screening Before Athletic Participation: An Untapped Opportunity?
At a Glance
| Category | Detail |
|---|---|
| Condition | Underlying cardiovascular disease in competitive athletes |
| Key Mechanisms | Preparticipation screening (PPS) including personal/family history, physical exam, resting ECG, submaximal exercise testing with ECG monitoring, and second line evaluations |
| Target Population | Competitive athletes across age spectrum (children to middle age) |
| Care Setting | Sports medicine centers within private healthcare system |
Key Highlights
- 7.6% of athletes required second line cardiovascular evaluation after initial PPS
- 0.34% of PPS exams identified high-risk cardiovascular conditions, increasing with age
- Considerable variability in abnormal ECG rates among physicians (0% to 7.1%) and age-dependent screening costs
Guideline-Based Recommendations
Diagnosis
- PPS should include structured personal and family history, physical examination, resting 12-lead ECG, and submaximal exercise testing with continuous ECG monitoring
- Second line evaluations (echocardiography, bicycle ergometry, 24-hour Holter monitoring) for athletes with suspicious findings on PPS
Management
- Referral for additional third line testing when diagnostic uncertainty persists after PPS and second line evaluation
Monitoring & Follow-up
- Continual reevaluation of PPS practices to ensure clinical benefit and resource optimization
Risks
- Variability in screening interpretation and diagnostic yield may affect accuracy
- Uncertain sensitivity and specificity of individual PPS components due to lack of linked diagnostic data
Patient & Prescribing Data
Competitive athletes aged ≤18 years to ≥35 years undergoing PPS in Italy
Screening yield and costs increase with age; basic clinical evaluation components contribute substantially to abnormal findings though their diagnostic value is unclear
Clinical Best Practices
- Implement structured PPS protocols including history, physical exam, ECG, and exercise testing
- Use second line cardiovascular testing selectively based on initial PPS findings
- Recognize variability in physician interpretation and strive for standardized training
- Continuously collect and analyze real-world data to refine screening strategies
- Consider cost-effectiveness and resource utilization in designing PPS programs
References
Based on findings from:
Preparticipation cardiac screening in athletes: still a diamond in the rough?
Aaron Baggish. European Journal Of Preventive Cardiology, 2025.
https://academic.oup.com/eurjpc/advance-article/doi/10.1093/eurjpc/zwaf666/8285552
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.